M2 Biologics is a new player in the growing field of Regenerative Medicine. Formed in 2019 by The McGee Group, a leading eyewear design and manufacturing firm, and NovaNet, the largest preferred medical provider network in the Southeast U.S., M2 Biologics is committed to pioneering this exciting new field, generating patient referrals, and improving the lives of end-users.
NovaNet first ventured into the emerging field of Regenerative Medicine with the intention of distributing selected products that were being offered to both medical providers and hospitals. The team assembled included experts in clinical practice, scientific research, and sales/marketing. While there were some production laboratories and manufacturers that met NovaNet’s requirements, there were gaps in what the team felt needed to be available. With that, NovaNet set out on the mission to having its designed products manufactured for them.
The first products that NovaNet worked with were for the ophthalmologic/optometric market—the “Eye Doctors.” The founder of NovaNet approached the founder of The McGee Group and saw the obvious potential in a partnership. As the concept matured and the new organization coalesced, M2 Biologics, LLC was born.